• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 67 of 100
How Valeant Is Justifying Its New Kinder, Gentler Drug Price Hikes
Health
How Valeant Is Justifying Its New Kinder, Gentler Drug Price Hikes
By Sy MukherjeeOctober 17, 2016
Mother sleeping with newborn baby on bed
Health
Homeopathic Treatments May Have Led to Deaths in Teething Babies
By Sy MukherjeeOctober 12, 2016
Novo Nordisk Chief Executive Officer Lars Soerensen Interview
Leadership
This Big Pharma Chief Was Just Named the World’s ‘Best-Performing’ CEO—Again
By Sy MukherjeeOctober 12, 2016
Cancer Consulting Elderly Person
Health
Why Pharma Giant Bristol-Myers Squibb’s Shares Took a Big Hit Today
By Sy MukherjeeOctober 10, 2016
Businessman with Duchenne muscular dystrophy in a motorized wheelchair working in an office
Health
The FDA’s Most Controversial Drug Approval of the Year Just Hit a Huge Snag
By Sy MukherjeeOctober 7, 2016
Alnylam’s Stock Is Plummeting After Drug Trial Leads to Patient Deaths
Health
Alnylam’s Stock Is Plummeting After Drug Trial Leads to Patient Deaths
By Sy MukherjeeOctober 6, 2016
Mylan CEO Heather Bresch Testifies On EpiPen Price Increases Before The House Oversight And Government Reform Committee
Health
Government Health Plans Spent Over $1 Billion on Mylan EpiPens Over 5 Years
By Fortune Editors and Reuters and Michelle TohOctober 6, 2016
CIO, 2 Others To Resign After JPMorgan Chase $2 Billion Trading Error
Retail
JPMorgan Is Pulling Chase ATMs from Walgreens Stores
By Reuters and Michelle TohOctober 4, 2016
Herceptin Approved For Treatment Of Scottish Breast Cancer Patients
Health
Samsung’s Biotech Unit Is Seeking Europe Approval for Its Copy of This Drug
By Reuters and Michelle TohOctober 3, 2016
House Oversight Committee Holds Hearing On Rising Price Of EpiPens With Mylan Inc. CEO Heather Bresch
Health
More and More Americans Think Prescription Drug Costs Are ‘Unreasonable’
By Chauncey L. AlcornSeptember 29, 2016
U.S. company stock buybacks are down 21 percent in the first seven months of 2016.
Health
Why Intra-Cellular Therapies’ Stock Got Crushed Today
By Sy MukherjeeSeptember 29, 2016
Shelley Ewalt
Retail
Target Pharmacy Customers Are Not Happy With Their New CVS Pill Bottles
By Madeline FarberSeptember 29, 2016
House Oversight Hearing On Prescription Drug Price Increases
Leadership
Martin Shkreli Is Auctioning Off a Chance to Punch Him in the Face
By Megan McCluskey, TIME and Michelle TohSeptember 28, 2016
This Biotech May Get the First Marijuana-Based Therapy Approved in the U.S.
Health
This Biotech May Get the First Marijuana-Based Therapy Approved in the U.S.
By Sy MukherjeeSeptember 26, 2016
Mylan CEO Heather Bresch Testifies On EpiPen Price Increases Before The House Oversight And Government Reform Committee
Health
3 Highly Dubious Claims Mylan’s CEO Made to Congress
By Sy MukherjeeSeptember 26, 2016
1...
  • 65
  • 66
  • 67
  • 68
  • 69
...100
Most Popular
Personal Finance
The $40 trillion national debt is growing while Social Security goes broke—because wealthy Boomers are collecting over $100k in benefits per yearplaceholder alt text
By Joshua HongAugust 27, 2026
Success
Welcome to the 'upper-middle-class trap': why $300,000 a year doesn't feel like winning anymoreplaceholder alt text
By Nick LichtenbergAugust 27, 2026
Cybersecurity
'You only get like two hours of alcohol or two hours of cigarettes a day': Former Meta engineer on child safety settlementplaceholder alt text
By Barbara Ortutay, Wyatte Grantham-Philips and The Associated PressAugust 27, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.